Collaborations with ManpowerGroup Philippines
Working Together to Save Lives
NanoHarmonics Inc. concluded its discussions with ManpowerGroup Philippines Inc. successfully. The discussions ended with ManpowerGroup Philippines Inc. issuing a formal Letter of Intent to NanoHarmonics Inc. An actual contract shall be executed between the two companies once commercial terms are finalized based on the project-specific human resource requirements of NanoHarmonics Inc. is determined.
This collaboration is important to NanoHarmonics Inc.in several ways. For one, ManpowerGroup has been voted the most ethical company for 13 straight years. Its reputation is unquestionable. It has presence in more than 70 countries all around the world. ManpowerGroup Philippines Inc. shall provide the human resource but help provide management expertise to help NanoHarmonics Inc. meet targets and achieve objectives. ManpowerGroup Philippines agreed to provide and manage human resource requirements for the population-study that may involve testing thousands of people for Malarial infection. In parallel to the implementation of the population study, ManPowerGroup shall work with NanoHarmonics Inc. to build a local commercialization team that will work with regional and local pharmaceutical distribution partners to market the products of NanoHarmonics.
We have the foundational technology to develop rapid and quantitative diagnostics tests for different biomarkers using Quantum Dots. The quantitative features as well as the accuracy levels of our tests make them ideal for immunity level detection, biomarker monitoring in drug development, infectious diseases management through population studies for predictive models, and biomarkers trends monitoring for personal health.
We are developing a companion secured and encrypted data platform for our Quantum Dot diagnostics. Numerical data from test results will be organized and managed to allow people to monitor trends of biomarkers associated with their health concerns, anonymized positive or negative population data for infectious diseases management, and monitor biomarkers to accelerate drug development for pharmaceutical companies.
We are partnering with several companies who bring novel drug delivery systems that will benefit from our Quantum Dot diagnostics technology and our data platform to participate in population studies that we are spearheading to create predictive models for infectious diseases. We are helping in the formulation of new drugs with potential increases in the bioavailability of beneficial APIs while substantially reducing toxicity and side effects.